$0.93
-40%OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
ONMD • NASDAQ
| OneMedNet Corporation Cash Flow Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
-10.1M | -33.8M | -30.5M | -2.9M | -2.8M | |
57K | 28K | 25K | 14.5K | 13.9K | |
628K | 1.5M | 1.9M | 97.9K | 606.5K | |
956K | 26.9M | 23.9M | 0.0 | -234.5K | |
(18K) | (0.0) | (0.0) | (0.0) | (0.0) | |
1.5M | 611K | -29K | 984.1K | 310.6K | |
-7M | -4.8M | -4.7M | -1.8M | -2.1M | |
INVESTING ACTIVITIES | |||||
-51K | -44K | -58K | -29.9K | (0.0) | |
-2.9M | (0.0) | (0.0) | (0.0) | (0.0) | |
969K | 0.0 | 0.0 | 0.0 | 0.0 | |
-2M | -44K | -58K | -29.9K | (0.0) | |
FINANCING ACTIVITIES | |||||
6.1M | 0.0 | -85.7M | 0.0 | 0.0 | |
3.1M | 6.1M | 5.1M | 2.5M | 1.3M | |
-200K | (0.0) | -88.5M | (0.0) | (0.0) | |
-100K | -1.5M | 84.9M | 0.0 | 0.0 | |
9.1M | 4.6M | 4.3M | 2.5M | 1.3M | |
CASH FLOW SUMMARY | |||||
0.0 | 0.0 | 0.0 | 0.0 | -22.4K | |
125K | -224K | -428K | 620.1K | -816.1K | |
47K | 271K | 699K | 79.2K | 895.2K | |
172K | 47K | 271K | 699.3K | 79.2K | |
-7M | -4.8M | -4.8M | -1.9M | -2.1M |
ONMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2025 Q3 Q3 | November 14, 2025 | September 30, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 09, 2025 | October 08, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 15, 2025 | September 11, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 13, 2025 | June 30, 2025 | 2025 | |
S-1/A S-1/A (Amended) N/A | July 14, 2025 | July 14, 2025 | ||
8-K 8-K 2025 N/A | July 11, 2025 | July 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | July 08, 2025 | July 08, 2025 | 2025 | |
S-1/A S-1/A (Amended) N/A | June 25, 2025 | June 25, 2025 |
Continue your ONMD research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.